Synopsys (SNPS) Exec Chair Aart de Geus Exercises Options, Sells Shares

What Happened

• Aart de Geus, Executive Chair of Synopsys, exercised stock options and immediately sold most of the shares. On 2026-08-31 he exercised 25,000 shares at $135.88 (cost $3,397,000) and sold 25,000 shares at a weighted avg $441.76 (proceeds $11,044,115). On 2026-09-01 he exercised 24,641 shares at $135.88 (cost $3,348,219) and sold 24,641 shares at a weighted avg $419.44 (proceeds $10,335,424). Combined, the exercises cost ~$6.75M and the open‑market sales generated gross proceeds of ~$21.38M. He also acquired 22 shares on 2026-08-31 for $360.96 ($7,941), reported as an ESPP acquisition (see footnote).

Key Details

• Transaction dates: 2026-08-31 and 2026-09-01 (filed on 2026-09-02). Filing appears timely relative to the trade dates.
• Exercise details: 25,000 and 24,641 shares exercised at $135.88 per share; corresponding derivative positions reported as disposed at $0.00 (i.e., option converted).
• Sales: weighted avg sale prices reported as $441.76 (range $435.88–$445.70) and $419.44 (range $413.99–$430.26); the reporting person can provide per-price breakdown on request (F1, F3).
• Small acquisition: 22 shares at $360.96 under the Employee Stock Purchase Plan (F2).
• Trades effected pursuant to a Rule 10b5-1 trading plan adopted October 14, 2025 (F4).
• Shares owned after the transactions are not disclosed in the provided filing excerpt.

Context

• These transactions were effectively a cashless exercise: options were exercised and the resulting shares were sold in the open market the same days. Such exercises with immediate sales are commonly routine monetizations, especially when done under a preexisting 10b5-1 plan. This summary is factual and does not speculate on motivations.